|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
Novonesis expands global footprint with acquisition of production facility in Southeast Asia
|
|
Saturday, 11 April, 2026, 08 : 00 AM [IST]
|
|
Copenhagen, Denmark
|
Novonesis has signed an agreement with Meihua to acquire a production facility in Rayong, Thailand for around USD 50 million, increasing the company’s footprint in Southeast Asia and strengthening its ability to serve customers worldwide.
Expanding in Asia is core to its ‘Grow’ strategy towards 2030. Emerging markets already account for one third of the company's sales and are expected to grow faster than developed markets. By investing in geographically well-positioned facilities, the company strengthens its capabilities to supply both local and global markets with its unique global multipurpose production setup.
The company is acquiring a facility with advanced fermentation capabilities that can be further expanded to support the company’s growth journey, including the production of HMO (human milk oligosaccharides). It plans to invest further in the facility over the coming years to maximise its potential and establish a strong operational setup. The company expects the site to be commercially operational in 2027.
Anders Lund, chief operating officer, said, “Strengthening our production footprint in Southeast Asia is an important step for Novonesis. A key part of our GROW strategy is to continue to strengthen our resilient and responsive supply network to support our long-term growth ambitions. By expanding our world-class production capabilities, we can move closer to customers in a fast-growing region and deliver even greater value to them."
|
|
|
|
|
|
|
|
|
|